|
1
|
Modlin IM, Lye KD and Kidd M: A 5-decade
analysis of 13715 carcinoid tumors. Cancer. 97:934–959. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naito S, Naito M, Yamamoto N, Kume T,
Hosino S, Kinjyo Y, Naito Y, Naito H and Hasegawa S: Polypoid
gallbladder neuroendocrine tumor diagnosed as benign polyp before
surgery: A case report. Mol Clin Oncol. 12:225–229. 2020.PubMed/NCBI
|
|
3
|
Dogra VS and Poblete J: Metaatatic
carcinoid tumor in the liver. J Clin Ultrasound. 21:639–641. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gustafsson BI, Kidd M and Modlin IM:
Neuroendocrine tumors of the diffuse neuroendocrine system. Curr
Opin Oncol. 20:1–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eltawil KM, Gustafsson BI, Kidd M and
Modlin IM: Neuroendocrine tumors of the gallbladder: An evaluation
and reassessment of management strategy. J Clin Gastroenterol.
44:687–695. 2010.PubMed/NCBI
|
|
6
|
Rothenstein J, Cleary SP, Pond GR, Dale D,
Gallinger S, Moore MJ, Brierley J and Siu LL: Neuroendocrine tumors
of the gastrointestinal tract: A decade of experience at the
princess margaret hospital. Am J Clin Oncol. 31:64–70. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oberg K: Diagnostic work-up of
gastroenteropancreatic neuroendocrine tumors. Clinics (Sao Paulo).
67 (Suppl 1):S109–S112. 2012. View Article : Google Scholar
|
|
8
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: Epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim J, Lee WJ, Lee SH, Lee KB, Ryu JK, Kim
YT, Kim SW, Yoon YB, Hwang JH, Han HS, et al: Clinical features of
20 patients with curatively resected biliary neuroendocrine
tumours. Dig Liver Dis. 43:965–970. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JM, Hwang S, Lee SG, Lee YJ, Park KM,
Kim KH, Ahn CS, Kim MH, Lee SK and Kim MW: Neuroendocrine tumors of
the gallbladder: Twelve cases in a single institution.
Hepatogastroenterology. 57:1064–1068. 2010.PubMed/NCBI
|
|
11
|
Chiorean L, Bartos A, Pelau D, Iancu D,
Ciuleanu T, Buiga R, Oancea I, Mangrau A, Iancu C and Badea R:
Neuroendocrine tumor of gallbladder with liver and retroperitoneal
metastases and a good response to the chemotherapeutical treatment.
J Med Ultrason (2001). 42:271–276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adachi T, Haraguchi M, Irie J, Yoshimoto
T, Uehara R, Ito S, Tokai H, Noda K, Tada N, Hirabaru M, et al:
Gallbladder small cell carcinoma: A case report and literature
review. Surg Case Rep. 2:712016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yun SP, Shin N and Seo HI: Clinical
outcomes of small cell neuroendocrine carcinoma and adenocarcinoma
of the gallbladder. World J Gastroenterol. 21:269–275. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duffy A, Capanu M, Abou-Alfa GK, Huitzil
D, Jarnagin W, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH and
O'Reilly EM: Gallbladder cancer (GBC): 10-year experience at
memorial sloan-kettering cancer center (MSKCC). J Surg Oncol.
98:485–489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komori Y, Yada K, Ohta M, Uchida H,
Iwashita Y, Fukuzawa K, Kashima K, Yokoyama S, Inomata M and Kitano
S: Mammalian target of rapamycin signaling activation patterns in
pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci.
21:288–295. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Missiaglia E, Dalai I, Barbi S, Beghelli
S, Falconi M, della Peruta M, Piemonti L, Capurso G, Di Florio A,
delle Fave G, et al: Pancreatic endocrine tumors: Expression
profiling evidences a role for AKT-mTOR pathway. J Clin Oncol.
28:245–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scoazec JY: Angiogenesis in neuroendocrine
tumors: Therapeutic applications. Neuroendocrinology. 97:45–56.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luttges J: What's new? The 2010 WHO
classification for tumours of the pancreas. Pathologe. 32 (Suppl
2):S332–S336. 2011.(In German).
|
|
19
|
Bosman FT, Camelr F, Hruban RH and Theise
ND: World Health Organization classification of tumours of the
digestive system [M]. IARC Press; Lyon: pp. 195–334. 2010
|
|
20
|
Ayabe RI, Wach M, Ruff S, Martin S, Diggs
L, Wiemken T, Hinyard L, Davis JL, Luu C and Hernandez JM: Primary
gallbladder neuroendocrine tumors: Insights into a rare histology
using a large national database. Ann Surg Oncol. 26:3577–3585.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bae JS, Kim SH, Yoo J, Kim H and Han JK:
Differential and prognostic MRI features of gallbladder
neuroendocrine tumors and adenocarcinomas. Eur Radiol. Feb
5–2020.(Epub ahead of print). doi: 10.1007/s00330-019-06588-9.
View Article : Google Scholar
|
|
22
|
Moskal TL, Zhang PJ and Nava HR: Small
cell carcinoma of the gallbladder. J Surg Oncol. 70:54–59. 1999.
View Article : Google Scholar
|
|
23
|
Fujimoto G, Yamada S, Kusanagi H and
Uegami W: Rapidly growing neuroendocrine carcinoma of the
gallbladder: A case report. Radiol Case Rep. 15:259–265. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chakrabarti D, Qayoom S, Ghosh A and Gupta
R: Neuroendocrine carcinoma of the gall bladder in a young lady
presenting with upper abdominal heaviness: A common complaint and a
rare diagnosis. BMJ Case Rep. 12:e2296842019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Skalický A, Vištejnová L, Dubová M, Malkus
T, Skalický T and Troup O: Mixed neuroendocrine-non-neuroendocrine
carcinoma of gallbladder: Case report. World J Surg Oncol.
17:552019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimono C, Suwa K, Sato M, Shirai S,
Yamada K, Nakamura Y and Makuuchi M: Large cell neuroendocrine
carcinoma of the gallbladder: Long survival achieved by multimodal
treatment. Int J Clin Oncol. 14:351–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Neyaz A, Husain N, Gupta S, Kumari S,
Arora A, Awasthi NP, Malhotra KP and Misra S: Investigation of
targetable predictive and prognostic markers in gallbladder
carcinoma. J Gastrointest Oncol. 9:111–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adachi T, Haraguchi M, Irie J, Yoshimoto
T, Uehara R, Ito S, Tokai H, Noda K, Tada N, Hirabaru M, et al:
Gallbladder small cell carcinoma: A case report and literature
review. Surg Case Rep. 2:712016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nishigami T, Yamada M, Nakasho K, Yamamura
M, Satomi M, Uematsu K, Ri G, Mizuta T and Fukumoto H: Cacinoid
tumor of the gall bladder. Intern Med. 35:953–956. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Handra-Luca A: Gallbladder neuroendocrine
carcinoma: Metastasis or synchronous tumor? Minerva Chir.
73:619–620. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu W, Chen W, He X, Qu Q, Hong T and Li
B: Cholecystectomy with gallbladder bed cautery might be sufficient
for T1bN0M0 neuroendocrine carcinoma of gallbladders: Cases report
and literature review. Medicine (Baltimore). 96:e87782017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hussain I, Sarvepalli D, Zafar H, Jehanzeb
S and Ullah W: Neuroendocrine tumor: A rare, aggressive tumor of
the gallbladder. Cureus. 11:e55712019.PubMed/NCBI
|
|
33
|
Liu W, Chen W, Chen J, Hong T, Li B, Qu Q
and He X: Neuroendocrine carcinoma of gallbladder: A case series
and literature review. Eur J Med Res. 24:82019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Soga J: Carcinoids and their variant
endocrinomas. An analysis of 11,842 reported cases. J Exp Clin
Cancer Res. 22:517–530. 2003.PubMed/NCBI
|
|
35
|
Yadav R, Jain D, Mathur SR and Iyer VK:
Cytomorphology of neuroendocrine tumours of the gallbladder.
Cytopathology. 27:97–102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peracchi M, Gebbia C, Basilisco G,
Quatrini M, Tarantino C, Vescarelli C, Massironi S and Conte D:
Plasma chromogranin A in patients with autoimmune chronic atrophic
gastritis, enterochromaffin-like cell lesions and gastric
carcinoids. Eur J Endocrinol. 152:443–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Monier A, Saloum N, Szmigielski W,
Alrashid A and Napaki SM: Neuroendocrine tumor of the gallbladder.
Pol J Radiol. 80:228–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leem G, Chung MJ, Park JY, Bang S, Song
SY, Chung JB and Park SW: Clinical value of contrast-enhanced
harmonic endoscopic ultrasonography in the differential diagnosis
of pancreatic and gallbladder masses. Clin Endosc. 51:80–88. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sugimoto M, Takagi T, Suzuki R, Konno N,
Asama H, Watanabe K, Nakamura J, Kikuchi H, Waragai Y, Takasumi M,
et al: Contrast-enhanced harmonic endoscopic ultrasonography in
gallbladder cancer and pancreatic cancer. Fukushima J Med Sci.
63:39–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Reimão S, Francioni E, Bories E, Caillol
F, Pesenti C and Giovannini M: Endoscopic ultrasonography-guided
bi-lateral biliary drainage: A case series study. Endosc
Ultrasound. 3 (Suppl 1):S182014.PubMed/NCBI
|
|
41
|
Samad A, Kaplan A, Arain M, Attam R,
Jessurun J, Manivel JC and Pambuccian SE: Endoscopic
ultrasound-guided fine-needle aspiration diagnosis of large cell
neuroendocrine carcinoma of the gallbladder and common bile duct:
Report of a case. Diagn Cytopathol. 41:1091–1095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abutaka A, El-Matbouly M, Helmy I,
Elmoghazy W, Sulieman I, Ben Gashir M, Soofi M, Khalaf H and
Elaffandi A: Repeat liver resection for pure large cell
neuroendocrine carcinoma of the gallbladder: A favorable outcome.
World J Surg Oncol. 17:1262019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Iype S, Mirza TA, Pmpper DJ, Bhattacharya
S, Feakins RM and Kocher HM: Neuroendocrine tumours of the
gaHbladder: Three cases and a review of the literature. Postgrad
Med J. 85:213–218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hirose Y, Sakata J, Endo K, Takahashi M,
Saito R, Imano H, Kido T, Yoshino K, Sasaki T and Wakai T: A 0.8-cm
clear cell neuroendocrine tumor G1 of the gallbladder with lymph
node metastasis: A case report. World J Surg Oncol. 16:1502018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
You YH, Choi DW, Heo JS, Han IW, Choi SH,
Jang KT and Han S: Can surgical treatment be justified for
neuroendocrine carcinoma of the gallbladder? Medicine (Baltimore).
98:e148862019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun YW and Liu DJ: Neuroendocrine
carcinoma of the gallbladder. Chin J Pract Surg. 31:265–267.
2011.(In Chinese).
|
|
47
|
Garg PK, Pandey D and Sharma J: The
surgical management of gallbladder cancer. Expert Rev Gastroenterol
Hepatol. 9:155–166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Machairas N, Paspala A, Frountzas M,
Tsilimigras DI, Moris D, Ntomi V, Tsapralis D and Schizas D: Mixed
adenoneuroendocrine carcinoma (MANEC) of the gallbladder: A
systematic review of outcomes following surgical management. In
Vivo. 33:1721–1726. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Elm'hadi C, Zerrik M, Errihani H and Ichou
M: A long survival woman with primary small-cell carcinoma of the
gallbladder: Role of chemotherapy maintenance. Cureus.
9:e13682017.PubMed/NCBI
|
|
50
|
Shoushtari AN, Bluth MJ, Goldman DA, Bitas
C, Lefkowitz RA, Postow MA, Munhoz RR, Buchar G, Hester RH, Romero
JA, et al: Clinical features and response to systemic therapy in a
historical cohort of advanced or unresectable mucosal melanoma.
Melanoma Res. 27:57–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tani S, Yamagishi S, Fukunaga K, Morita M,
Sonoda T, Murao S, Ikuta S, Kakuno A and Yamanaka N: A case of
disease-free, long survival in a patient with mixed
adenoneuroendocrine carcinoma of the gallbladder treated with
induction CDDP/CPT-11 chemotherapy and resection. Gan To Kagaku
Ryoho. 42:113–117. 2015.(In Japanese). PubMed/NCBI
|
|
52
|
Smith JL and Davis BR: Neuroendocrine
tumor of the gallbladder treated with neoadjuvant chemotherapy and
surgery. Am Surg. 80:318–320. 2014.PubMed/NCBI
|
|
53
|
Elahi F, Ahmadzadeh A, Yadonahzadeh M,
Hassanpour K and Babaei M: Neuroendocrine tumor of the gallbladder.
Arch Iran Med. 16:123–125. 2013.PubMed/NCBI
|
|
54
|
Okuyama Y, Fukui A, Enoki Y, Morishita H,
Yoshida N and Fujimoto S: A large cell neuroendocrine carcinoma of
the gall bladder: Diagnosis with 18FDGPET/CT-guided
biliary cytology and treatment with combined chemotherapy achieved
a long-term stable condition. Jpn J Clin Oncol. 43:571–574. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Inoue D, Ozaka M, Muramatsu Y, Yamada I,
Matsuyama M, Kanda H and Ishii H: Neuroendocrine gallbladder cancer
treated with cisplatin plus irinotecan-A case report. Gan To Kagaku
Ryoho. 41:765–767. 2014.(In Japanese). PubMed/NCBI
|
|
56
|
Barakat MT, Meeran K and Bloom SR:
Neuroendocrine tumours. Endocr Relat Cancer. 11:1–18. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pavel ME, Hassler G, Baum U, Hahn EG,
Lohmann T and Schuppan D: Circulating levels of angiogenic
cytokines can predict tumour progression and prognosis in
neuroendocrine carcinomas. Clin Endocrinol (Oxf). 62:434–443. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Raymond E, Dahan L, Raoul JL, Bang YJ,
Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A,
et al: Sunitinib malate for the treatment of pancreatic
neuroendocrine tumors. N Engl J Med. 364:501–513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yao JC, Shah MH, Ito T, Bohas CL, Wolin
EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG,
et al: Everolimus for advanced pancreatic neuroendocrine tumors. N
Engl J Med. 364:514–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Caplin ME, Pavel M, Cwikla JB, Phan AT,
Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L,
et al: Lanreotide in metastatic enteropancreatic neuroendocrine
tumors. N Engl J Med. 371:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Igaz P: Efficacy of somatostatin analogues
in the treatment of neuroendocrine tumours based on the results of
recent clinical trials. Orv Hetil. 155:1908–1912. 2014.(In
Hungarian). View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Oberg K, Akerstrom G, Rindi G and Jelic S;
ESMO Guidelines Working Group, : Neuroendocrine
gastroenteropancreatic tumours: ESMO clinical practice guidelines
for diagnosis, treatment and follow-up. Ann Oncol. 21 (Suppl
5):v223–v227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lin PC, Lai YC, Lai JI, Hsu SY and Wang
WS: Successful treatment of gallbladder neuroendocrine carcinoma
with combined chemo-radiotherapy: A case report and literature
review. Int J Clin Pharmacol Ther. 49:403–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kwekkeboom DJ, de Herder WW, Kam BL, van
Eijck CH, van Essen M, Kooij PP, Feelders RA, van Aken MO and
Krenning EP: Treatment with the radiolabeled somatostatin analog
[177 Lu-DOTA 0, Tyr3] octreotate: Toxicity, efficacy, and survival.
J Clin Oncol. 26:2124–2130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Roversi R, Ricci S, Rossi G, Roversi M and
Cavallo G: Locoregional therapy with hypoxic liver perfusion in
malignant neoplasms of the gallbladder. Preliminary experience.
Radiol Med. 94:220–225. 1997.(In Italian). PubMed/NCBI
|
|
66
|
Garin E, Rolland Y, Boucher E, Ardisson V,
Laffont S, Boudjema K, Bourguet P and Raoul JL: First experience of
hepatic radioembolization using microspheres labelled with
yttrium-90 (TheraSphere): Practical aspects concerning its
implementation. Eur J Nucl Med Mol Imaging. 37:453–461. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kamei K, Shindoh J, Kiya Y, Matsumoto I,
Hashimoto M and Takeyama Y: Conversion surgery after extensive
chemotherapy for stage IV mixed adenoneuroendocrine carcinoma
(MANEC) of the gallbladder: Clinical implications from the patterns
of response and recurrence. Clin J Gastroenterol. Oct 15–2019.(Epub
ahead of print). doi: 10.1007/s12328-019-01053-y. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Salimi Z and Sharafuddin M: Ultrasound
appearance of primary carcinoid tumor of the gallbladder associated
with carcinoid syndrome. J Clin Ultrasound. 23:435–437. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Soga J: Primary endocrinomas (carcinoids
and variant neoplasms) of the gallbladder: A statistical evaluation
of 138 reported cases. J Exp Clin Cancer Res. 22:5–15.
2003.PubMed/NCBI
|
|
70
|
Pantongrag-Brown L, Buetow PC, Carr NJ,
Lichtenstein JE and Buck JL: Calcification and fibrosis in
mesenteric carcinoid tumor: CT findings and pathologic correlation.
AJR Am J Roentgenol. 164:387–391. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Shapera E and Bitting C: Survival: A rare
outcome in large cell neuroendocrine carcinoma of the gallbladder.
Acta Gastroenterol Belg. 82:433–436. 2019.PubMed/NCBI
|
|
72
|
Deshmukh SD, Gulati HK, Gaopande V,
Purandare S and Anand M: Incidental cystic endocrine tumor of the
pancreas: A case report with immunohistochemical study. J Cancer
Res Ther. 8:289–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Iwasa S, Morizane C, Okusaka T, Ueno H,
Ikeda M, Kondo S, Tanaka T, Nakachi K, Mitsunaga S, Kojima Y, et
al: Cisplatin and etoposide as first-line chemotherapy for poorly
differentiated neuroendocrine carcinoma of the hepatobiliary tract
and pancreas. Jpn J Clin Oncol. 40:313–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
